Sutro Biopharma ( ($STRO) ) has released its Q3 earnings. Here is a breakdown of the information Sutro Biopharma presented to ...

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

VEGF bispecifics. | Merck and BioNTech are buying Chinese biotechs to gain PD-(L)1/VEGF bispecifics. AstraZeneca's CEO argued ...

BioNTech SE and Biotheus announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage ...

Equities researchers at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report issued on Friday. The brokerage set a “hold” rating on the ...

Mersana Therapeutics ( (MRSN) ) has released its Q3 earnings. Here is a breakdown of the information Mersana Therapeutics presented to its ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.

- Secures $3.2m in PIPE Financing - - $50m Term Sheet Obtained for Available Financing under Equity Line of Credit - ...

As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug ...

An announcement from Akari Therapeutics ( (AKTX) ) is now available. Akari Therapeutics has completed its merger with Peak Bio, enhancing its ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...